Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02189 vs HCA, THC, EHC: Buyback Yield % Comparison
For the Medical Care Facilities subindustry, Kato (Hong Kong) Holdings's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kato (Hong Kong) Holdings Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Kato (Hong Kong) Holdings's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Kato (Hong Kong) Holdings's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kato (Hong Kong) Holdings (HKSE:02189) has a Buyback Yield % of 0.00 as of Aug. 31, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Kato (Hong Kong) Holdings and its competitors. According to the industry distribution chart, Kato (Hong Kong) Holdings ranks #999999 out of 242 companies in the Healthcare Providers & Services industry.
Is Kato (Hong Kong) Holdings' Buyback Yield % too high?
Kato (Hong Kong) Holdings' current Buyback Yield % is 0.00. Based on the distribution chart, Kato (Hong Kong) Holdings ranks #999999 out of 242 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Kato (Hong Kong) Holdings has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Kato (Hong Kong) Holdings' Buyback Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Kato (Hong Kong) Holdings ranks #999999 out of 242 companies for Buyback Yield %. This places Kato (Hong Kong) Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Kato (Hong Kong) Holdings and its competitors. Kato (Hong Kong) Holdings's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kato (Hong Kong) Holdings stock overvalued right now?
Based on GuruFocus' analysis, Kato (Hong Kong) Holdings (HKSE:02189) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.53, compared to a current price of HK$0.50 — trading 6.6% below its estimated fair value. The current Buyback Yield % is 0.00. Kato (Hong Kong) Holdings' overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Kato (Hong Kong) Holdings (HKSE:02189), the current Buyback Yield % is 0.00 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kato (Hong Kong) Holdings (HKSE:02189) Overvalued in 2026?
Based on GuruFocus' analysis, Kato (Hong Kong) Holdings stock appears to be undervalued.
The current stock price of HK$0.50 is trading 6.6% below its estimated GF Value™ of HK$0.53.
GuruFocus considers Kato (Hong Kong) Holdings to be Fairly Valued.
Key valuation signals for HKSE:02189:
Buyback Yield %: 0.00
GF Value™: HK$0.53 vs. price of HK$0.50 (6.6% below fair value)
No single metric tells the full story. See the HKSE:02189 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kato (Hong Kong) Holdings Ltd is an established operator of residential care homes and daycare services for the elderly in Hong Kong. The company offers a wide range of residential care services for the elderly including; the provision of accommodation, professional nursing and care-taking services, nutritional management, medical services, physiotherapy and occupational therapy services, individual care plans and recreational services, and the sale of healthcare and medical goods and the provision of additional healthcare services to residents.
63GF Score
Get the complete analysis for HKSE:02189
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02189 has been successfully added to your 
